Gingival DiseasesPhase 3NCT00758290
Clinical Study to Evaluate Dental Plaque
A Phase 3 study testing Triclosan/Fluoride and Fluoride/triclosan in people with Gingival Diseases, run by Colgate Palmolive at 1 site in United States.
Trial summary
Clinical research study to determine anti-plaque efficacy of a prototype toothpastes for a 3 week brushing regiment. Read more about this study
- Who is it for?
- Ages 20 to 51 yearsHealthy volunteers can take part
- Conditions the study is for
- Gingival Diseases
- What is being tested?
- Triclosan/Fluoride and Fluoride/triclosan
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 23 participants
- Where
- 1 siteUnited States
- Study dates
- May 2008to Jul 2008
- Phase
- Phase 3
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 51 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Male or female volunteers at least 20 - 51 years of age
- Good general health
- Must sign informed consent form
- Minimum of 15 natural uncrowned teeth (excluding third molars) must be present
- No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study
Who cannot join
- Subjects unable or unwilling to sign the informed consent form
- Medical condition which requires pre-medication prior to dental visits/procedures
- Moderate or advanced periodontal disease or heavy dental tartar (calculus)
- 5 or more decayed untreated dental sites at screening (cavities)
- Other disease of the hard or soft oral tissues.
- Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation).
Show all 17Show fewer
- Use of medications that are currently affecting salivary function
- Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1
- Pregnant or nursing women
- Participation in any other clinical study within 1 week prior to enrollment into this study
- Use of tobacco products
- Subjects who must receive dental treatment during the study dates
- Current use of Antibiotics for any purpose
- Presence of an orthodontic appliance which interferes with plaque scoring
- History of allergy to common toothpaste ingredients
- History of allergy to arginine (amino acid)
- Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy)
Trial locations and contacts
1 site in 1 country.
United States1 site
Bluestone Center for Clinical Research, NYU College of Dentistry
New York, New York, 10016
About this study
Clinical research study to determine anti-plaque efficacy of a prototype toothpastes for a 3 week brushing regiment.
- Conditions
- Gingival Diseases
- Being tested
- Triclosan/Fluoride, Fluoride/triclosan
- Medical subject headings
- Gingival Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Triclosan/FluorideDrug
Brush twice daily for 3 weeks
Fluoride/triclosanDrug
Brush daily for 3 weeks
| Study group | Role | What they receive |
|---|---|---|
| A | Active comparator | Not described Receives: Drug: Triclosan/Fluoride |
| B | Experimental | Not described Receives: Drug: Fluoride/triclosan |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dental Plaque Index
Plaque units measured on a scale between 0 to 5. No plaque=0;5=2/3 of tooth covered in plaque
Measured: 4 Day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Sep 2008 (estimated)
- Study startMay 2008
- Primary completionJul 2008
- Study completionJul 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Gingival DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 23 participants (actual)
Sponsor and investigators
- Lead sponsor
- Colgate Palmolive
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Patricia Corby, DDS, Principal investigator
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00758290
- Sponsor's protocol ID
- CRO-2008-PLA-13-RR
- Status last verified
- Nov 2008
- First submitted
- 23 Sep 2008
- Last updated
- 25 Nov 2008
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Nov 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Study to Evaluate Dental Plaque
- ClinicalTrials.gov ID
- NCT00758290
- Acronym / sponsor ID
- CRO-2008-PLA-13-RR
- Conditions
- Gingival Diseases
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 23 participants (actual)
- Lead sponsor
- Colgate PalmoliveIndustry (pharma, biotech, devices)
- Study start
- May 2008
- Primary completion
- Jul 2008 (actual)
- Study completion
- Jul 2008 (actual)
- First posted
- 25 Sep 2008 (estimated)
- Results
- Posted 25 Nov 2008
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Clinical research study to determine anti-plaque efficacy of a prototype toothpastes for a 3 week brushing regiment.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| A | Active comparator | Drug: Triclosan/Fluoride |
| B | Experimental | Drug: Fluoride/triclosan |
Who may qualify
- Ages
- 20 to 51 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Male or female volunteers at least 20 - 51 years of age
- Good general health
- Must sign informed consent form
- Minimum of 15 natural uncrowned teeth (excluding third molars) must be present
- No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study
Key exclusion criteria (17 listed)
- Subjects unable or unwilling to sign the informed consent form
- Medical condition which requires pre-medication prior to dental visits/procedures
- Moderate or advanced periodontal disease or heavy dental tartar (calculus)
- 5 or more decayed untreated dental sites at screening (cavities)
- Other disease of the hard or soft oral tissues.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Triclosan/FluorideBrush twice daily for 3 weeks | Drug | A |
| Fluoride/triclosanBrush daily for 3 weeks | Drug | B |
Primary outcome
Dental Plaque Index
Time frame: 4 Day
Plaque units measured on a scale between 0 to 5. No plaque=0;5=2/3 of tooth covered in plaque
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Nov 2008.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Gingival Diseases
Not yet recruiting
Spirulina Gel in the Treatment of Periodontitis
Periodontitis, Periodontitis Stage II
Not yet recruiting
Effectiveness of Oil Pulling Using Oils in Comparison With Mouthwash for Gingivitis
Gingivitis
Not yet recruitingObservational study
Circadian Clock Proteins in Gingival Crevicular Fluid of Individuals With and Without Circadian Rhythm Disruption
Gingivitis, Circadian Rhythm Disruption
Recruiting
Cryotherapy, PGE2, NGF Levels and Pain After Endodontic Retreatment
Asymptomatic Apical Periodontitis, Endodontic Retreatment
RecruitingObservational study
Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
Immunosuppression, Periodontal Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Patricia Corby, DDS principal investigator
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Triclosan/Fluoride and Fluoride/triclosan in people with Gingival Diseases, run by Colgate Palmolive at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Nov 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Yes. Results are posted in the registry (first posted 25 Nov 2008). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dental Plaque Index (time frame: 4 Day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2008.